← Open Payments lookup

SURINDER RANDHAWA: Open Payments

NPI 1952337123 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$922 in 54 payments from 9 companies in 2025. Trend: 2023 $610 · 2024 $550 · 2025 $922

Food & beverage: $922
CompanyPaymentsAmount
ABBVIE INC.15$208
Neurocrine BioSciences, Inc.10$144
Otsuka America Pharmaceutical, Inc.8$137
Teva Pharmaceuticals USA, Inc.5$104
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$98
Janssen Pharmaceuticals, Inc4$72
Alkermes, Inc.2$63
E.R. Squibb & Sons, L.L.C.3$56
Axsome Therapeutics, Inc.2$41

Products named: VRAYLAR, INGREZZA, REXULTI, CAPLYTA, ARISTADA, UZEDY, COBENFY, SPRAVATO.

Industry payments across OK — which companies pay providers there.